TI
Trexquant Investment Portfolio holdings
AUM
$8.86B
1-Year Return
23.46%
This Quarter Return
+8.83%
1 Year Return
+23.46%
3 Year Return
+83.97%
5 Year Return
+134.74%
10 Year Return
+204.61%
AUM
$3.53B
AUM Growth
+$683M
(+24%)
Cap. Flow
+$524M
Cap. Flow
% of AUM
14.86%
Top 10 Holdings %
Top 10 Hldgs %
10.35%
Holding
1,865
New
559
Increased
440
Reduced
326
Closed
540
Top Buys
| 1 |
Apple
AAPL
|
+$47.1M |
| 2 |
Tesla
TSLA
|
+$44.1M |
| 3 |
Goldman Sachs
GS
|
+$40.6M |
| 4 |
Albemarle
ALB
|
+$34.7M |
| 5 |
Autodesk
ADSK
|
+$30.1M |
Top Sells
| 1 |
Boeing
BA
|
+$55.5M |
| 2 |
Phillips 66
PSX
|
+$34.2M |
| 3 |
S&P Global
SPGI
|
+$32.7M |
| 4 |
Procter & Gamble
PG
|
+$32.7M |
| 5 |
Cisco
CSCO
|
+$28.8M |
Sector Composition
| 1 | Technology | 24.73% |
| 2 | Consumer Discretionary | 14.62% |
| 3 | Healthcare | 12.93% |
| 4 | Financials | 11.55% |
| 5 | Industrials | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
1301
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $123K | ﹤0.01% |
16,763
+6,037
| +56% | +$44.4K |
|
|
PAYA
1302
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $123K | ﹤0.01% |
+15,651
| New | +$123K |
|
1303
Amplify Energy
AMPY
$161M
| $123K | ﹤0.01% |
13,987
-1,447
| -9% | -$12.7K |
|
|
CHS
1304
DELISTED
Chicos FAS, Inc.
CHS
| $123K | ﹤0.01% |
24,908
-273,572
| -92% | -$1.35M |
|
1305
OFS Capital
OFS
$116M
| $119K | ﹤0.01% |
+11,686
| New | +$119K |
|
1306
OP Bancorp
OPBK
$217M
| $118K | ﹤0.01% |
10,553
-8,224
| -44% | -$91.8K |
|
1307
NET Power
NPWR
$163M
| $117K | ﹤0.01% |
+11,547
| New | +$117K |
|
1308
Blue Bird Corp
BLBD
$1.82B
| $117K | ﹤0.01% |
10,929
-1,895
| -15% | -$20.3K |
|
|
MTLS
1309
Materialise
MTLS
$299M
| $117K | ﹤0.01% |
+13,269
| New | +$117K |
|
1310
Universal Insurance Holdings
UVE
$696M
| $112K | ﹤0.01% |
+10,549
| New | +$112K |
|
|
TSVT
1311
DELISTED
2seventy bio
TSVT
| $111K | ﹤0.01% |
+11,872
| New | +$111K |
|
1312
Century Therapeutics
IPSC
$43.9M
| $111K | ﹤0.01% |
21,541
-3,065
| -12% | -$15.7K |
|
1313
Cullinan Oncology
CGEM
$382M
| $108K | ﹤0.01% |
10,249
-13,408
| -57% | -$141K |
|
1314
scPharmaceuticals
SCPH
$301M
| $107K | ﹤0.01% |
+14,964
| New | +$107K |
|
1315
Mistras Group
MG
$301M
| $105K | ﹤0.01% |
21,268
-14,950
| -41% | -$73.7K |
|
1316
Generation Bio
GBIO
$40.3M
| $97.8K | ﹤0.01% |
2,488
-803
| -24% | -$31.6K |
|
1317
Erasca
ERAS
$440M
| $83.6K | ﹤0.01% |
19,403
-14,919
| -43% | -$64.3K |
|
1318
GrafTech
EAF
$199M
| $82K | ﹤0.01% |
+1,722
| New | +$82K |
|
1319
IHS Holding
IHS
$2.42B
| $77.7K | ﹤0.01% |
+12,633
| New | +$77.7K |
|
1320
Epsilon Energy
EPSN
$123M
| $77K | ﹤0.01% |
+11,613
| New | +$77K |
|
1321
Lincoln Educational Services
LINC
$601M
| $75K | ﹤0.01% |
+12,960
| New | +$75K |
|
|
BCOV
1322
DELISTED
Brightcove, Inc.
BCOV
| $65.3K | ﹤0.01% |
+12,482
| New | +$65.3K |
|
|
VIA
1323
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $59.6K | ﹤0.01% |
2,334
-2,847
| -55% | -$72.8K |
|
1324
XBiotech
XBIT
$85.4M
| $45.6K | ﹤0.01% |
12,985
-8,990
| -41% | -$31.6K |
|
|
MRNS
1325
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $40.6K | ﹤0.01% |
+10,213
| New | +$40.6K |
|